Get started
Acrivon Therapeutics, Inc.Acrivon Therapeutics, Inc.Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

Acrivon Therapeutics, Inc. SEC filings and other documents


Explore the latest company documents and SEC filings from Acrivon Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
Description
Event date
Documents and forms
2025
Q2 2025
Aug 13, 2025
Quarterly report10-Q
Earnings release8-K
Corporate Presentation
Jun 13, 2025
Slides
Q1 2025
May 14, 2025
Quarterly report10-Q
Earnings release8-K
Status Update
Mar 25, 2025
Slides
2024
Q4 2024
Mar 26, 2025
Earnings release8-K
Annual report10-K
Q3 2024
Nov 13, 2024
Quarterly report10-Q
Earnings release8-K
Study Update
Sep 14, 2024
Press release
Slides
Q2 2024
Aug 13, 2024
Earnings release8-K
Corporate Presentation
Jun 4, 2024
Slides
Q1 2024
May 14, 2024
Earnings release8-K
R&D Update
Apr 24, 2024
Slides
2023
Q4 2023
Mar 28, 2024
Annual report10-K
Earnings release8-K
Q3 2023
Nov 9, 2023
Earnings release8-K
Q2 2023
Aug 11, 2023
Earnings release8-K
Q1 2023
May 9, 2023
Earnings release8-K
2022
Q4 2022
Mar 28, 2023
Annual report10-K
Earnings release8-K